PF-06438179
B5371002
Phase 3 mab completed
Quick answer
PF-06438179 for Rheumatoid Arthritis is a Phase 3 program (mab) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed